Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1999 1
2005 1
2008 1
2011 1
2012 1
2013 4
2014 5
2015 3
2016 3
2017 7
2018 7
2019 5
2020 8
2021 9
2022 5
2023 3
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. JHEP Rep. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 39006503 Free PMC article.
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.
Dietz J, Müllhaupt B, Buggisch P, Graf C, Peiffer KH, Matschenz K, Schattenberg JM, Antoni C, Mauss S, Niederau C, Discher T, Trauth J, Dultz G, Schulze Zur Wiesch J, Piecha F, Klinker H, Müller T, Berg T, Neumann-Haefelin C, Berg CP, Zeuzem S, Sarrazin C; German HCV Resistance Study Group; University Hospitals; Academic Hospitals; Local study sites (private practices), Germany. Dietz J, et al. J Hepatol. 2023 Jan;78(1):57-66. doi: 10.1016/j.jhep.2022.08.016. Epub 2022 Aug 27. J Hepatol. 2023. PMID: 36031158
Author's Response.
Bierbaum MM, Curtis K, Mitchell R. Bierbaum MM, et al. J Paediatr Child Health. 2018 Aug;54(8):928. doi: 10.1111/jpc.14135. J Paediatr Child Health. 2018. PMID: 30133896 No abstract available.
Rates of adherence to cancer treatment guidelines in Australia and the factors associated with adherence: A systematic review.
Bierbaum M, Rapport F, Arnolda G, Tran Y, Nic Giolla Easpaig B, Ludlow K, Clay-Williams R, Austin E, Laginha B, Lo CY, Churruca K, van Baar L, Hutchinson K, Chittajallu R, Owais SS, Nullwala R, Hibbert P, Fajardo Pulido D, Braithwaite J. Bierbaum M, et al. Asia Pac J Clin Oncol. 2023 Dec;19(6):618-644. doi: 10.1111/ajco.13948. Epub 2023 Mar 7. Asia Pac J Clin Oncol. 2023. PMID: 36881529 Review.
Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature.
Bierbaum M, Rapport F, Arnolda G, Nic Giolla Easpaig B, Lamprell K, Hutchinson K, Delaney GP, Liauw W, Kefford R, Olver I, Braithwaite J. Bierbaum M, et al. Implement Sci. 2020 May 27;15(1):39. doi: 10.1186/s13012-020-00991-3. Implement Sci. 2020. PMID: 32460797 Free PMC article.
What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence.
Nic Giolla Easpaig B, Tran Y, Bierbaum M, Arnolda G, Delaney GP, Liauw W, Ward RL, Olver I, Currow D, Girgis A, Durcinoska I, Braithwaite J. Nic Giolla Easpaig B, et al. Among authors: bierbaum m. BMC Health Serv Res. 2020 Feb 10;20(1):102. doi: 10.1186/s12913-020-4939-7. BMC Health Serv Res. 2020. PMID: 32041593 Free PMC article.
61 results